substance p has been researched along with Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bumanglag, AV; Burke, SN; Chun, E; Sloviter, RS | 1 |
| de Lanerolle, NC; Eid, T; Kim, JH; Spencer, DD; Spencer, SS; Williamson, A; Zaveri, HP | 1 |
2 other study(ies) available for substance p and Sclerosis
| Article | Year |
|---|---|
Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats.
Topics: Animals; Chronic Disease; Dentate Gyrus; Epilepsy, Temporal Lobe; GABAergic Neurons; gamma-Aminobutyric Acid; Hippocampus; Male; Parvalbumins; Rats; Rats, Sprague-Dawley; Saporins; Sclerosis; Substance P | 2019 |
A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories.
Topics: Adult; Apoptosis; Cell Count; Culture Techniques; Dentate Gyrus; Dynorphins; Electroencephalography; Epilepsy, Temporal Lobe; Evoked Potentials; Female; Follow-Up Studies; Hippocampus; Humans; Immunoenzyme Techniques; Interneurons; Male; Neurons; Neuropeptide Y; Reference Values; Retrospective Studies; Sclerosis; Somatostatin; Substance P; Treatment Outcome | 2003 |